Table 2.
HR | 95% CI | p | ||
---|---|---|---|---|
Lower bound | Upper bound | |||
Bivariate analyses | ||||
Achieved HbA1c at study end in the active arm (HbA1c ≤ 7.0% vs HbA1c > 7.0%) vs MACE | ||||
All trials‡ (143 study arms; n = 270,874; 20,724 events) |
0.9579 | 0.8117 | 1.1097 | 0.256 |
SGLT2i, DPP4i, Pioglitazone or GLP1-RA in the active arm (73 study arms*; n = 197,498; 17,073 events) |
0.9062 | 0.7985 | 0.9673 | 0.017 |
Change in HbA1c in the active arm compared to control (each reduction of 1%) vs MACE | ||||
All trials∅ (143 study arms; n=270,874; 20,724 events) |
0.8979 | 0.7249 | 1.0171 | 0.109 |
SGLT2i, DPP4i, Pioglitazone or GLP1-RA in the active arm◇ (73 study arms*; n = 197,498; 17,073 events) |
0.8477 | 0.7395 | 0.9246 | <0.001 |
Multivariate analyses** | ||||
Achieved HbA1c at study end in the active arm (HbA1c ≤ 7.0% vs. HbA1c > 7.0%) vs. MACE | ||||
All trials‡‡ (121 study arms§; n = 243,713; 18,029 events) |
0.8785 | 0.6471 | 1.0820 | 0.162 |
SGLT2i, DPP4i, Pioglitazone or GLP1-RA in the active arm (60 study arms*§; n = 191,032; 16,126 events) |
0.8252 | 0.7111 | 0.9512 | 0.009 |
Change in HbA1c in the active arm compared to control (each reduction of 1%) vs. MACE | ||||
All trialsøø (119 study arms§; n = 240,227; 17,648 events) |
0.8837 | 0.7019 | 0.9991 | 0.049 |
SGLT2i, DPP4i, Pioglitazone or GLP1-RA in the active arm◇◇ (60 study arms*§; n = 191,032; 16,126 events) |
0.9046 | 0.7513 | 0.9798 | 0.011 |
Excluding RCTs with outlier HRs for MACE, defined as HR ≥ 2.0 or HR ≤ 0.5.
Adjusted for Time since the diagnosis of T2DM, follow-up time and type of ADT in the active arm. Adjusting variables were selected for their association with HR for MACE in bivariate analyses.
Some RCTs had missing data for covariates.
I2: 5.31%, QE = 83.17 (p = 0.95); tau2: 0.010 (SE = 0.022).
I2: 12.12%, QE = 53.32 (p = 0.93); tau2: 0.010 (SE = 0.022).
I2: 2.76%, QE = 92.10 (p = 0.98); tau2: 0.010 (SE = 0.022).
I2: 6.1%, QE = 67.55 (p = 0.98); tau2: 0.008 (SE = 0.023).
I2: 0%, QE = 73.21 (p = 0.95); tau2: 0.014 (SE = 0.012).
I2: 0%, QE = 7.29 (p = 0.20); tau2: 0.010 (SE = 0.021).
I2: 0%, QE = 85.56 (p = 0.98); tau2: 0.018 (SE = 0.027).
I2: 0%, QE = 77.32 (p = 0.96); tau2: 0.008 (SE = 0.028).